<DOC>
<DOCNO>
EP-0008277
</DOCNO>
<TEXT>
<DATE>
19800220
</DATE>
<IPC-CLASSIFICATIONS>
A61P-37/00 C07D-491/04 C07D-239/00 A61P-37/08 C07D-491/052 C07D-491/00 C07D-239/62 A61K-31/505 <main>C07D-491/052</main> A61P-43/00 
</IPC-CLASSIFICATIONS>
<TITLE>
benzopyrano derivatives, pharmaceutical compositions containing them and processes for preparing the compounds and compositions.
</TITLE>
<APPLICANT>
scherico ltdch<sep>scherico ltd.<sep>technobiotic ltd.töpferstrasse 5ch-6004 lucernech<sep>scherico ltd.<sep>
</APPLICANT>
<INVENTOR>
blythin david john<sep>blythin, david john<sep>blythin, david john487 mountain avenuecaldwell, new jersey 07006us<sep>blythin, david john<sep>blythin, david john487 mountain avenuecaldwell, new jersey 07006us<sep>
</INVENTOR>
<ABSTRACT>
novel compounds of the formula    wherein each of r₃ and r₅ represents hydrogen or loweralkyl, n  is an integer from one to four and r represents hydrogen,  loweralkyl, lowercycloalkyl, lowercycloalkyl-loweralkyl, acyloxy­ loweralkyl, hydroxyloweralkyl, lower-alkoxyloweralkyl, nitro,  halogeno, haloloweralkyl, hydroxy, loweralkoxy, acyl­ aminoloweralkyl, aminoloweralkyl, mono- or diloweralkyl­ aminoloweralkyl, alkanoyloxy, carboxy, loweralkoxycarbonyl,  acyl, formyl, cyano or a carboxamido moiety of the structure    wherein a is straight or branched chain alkyl with up to 12  carbon atoms, lowercycloalkyl, lowercycloalkylloweralkyl, low­ eralkoxyloweralkyl, hydroxyloweralkyl, fluoroloweralkyl, loweral­ kenyl, loweralkylthioloweralkyl, loweralkylsulfoxyloweralkyl, low­ eralkylsulfonylloweralkyl, thiazol, oxazolyl, thiadiazolyl,  methylthiadiazolyl, furyl, pyrazolyl, tetrazolyl, methyltetrazolyl,  hydroxypyrimidinyl, phenyl, pyrimidynyl-dione, or the grouping    wherein e is a straight or branched chain or cyclic  loweralkylene, x is zero or one and q is hydroxy, loweralkoxy,  amino or mono- or diloweralkylamino; or the grouping -e-r₈,  wherein e is as defined above and is optionally substituted by  hydroxy and/or phenyl, r₈ is phenyl, thiazolyl, oxazolyl,  thiadiazolyl, methylthiadiazolyl, tetrazolyl, methyltetrazolyl, furyl,  pyridyl, methylpyridyl or piperidinyl; and b is hydrogen, low­ eralkyl, lowercycloalkyl, lowercycloalkylloweralkyl, or loweral­ kenyl; or a and b, when taken together with the nitrogen atom to  which they are attached, represent imidazolyl, morpholinyl, pyr­ rolidinyl, piperidinyl or piperazinyl and heterocyclic rings being  optionally substituted by hydroxy, loweralkyl or hydroxy­ loweralkyl; and pharmaceutically acceptable salts thereof.  the preparation of these compounds by five methods is  described, in particular one inventive method which comprises  reacting a correspondingly r-substituted salicylaldehyde and 
</ABSTRACT>
</TEXT>
</DOC>
